Best-effort research profile: this record has not passed full two-source scientific verification. Descriptive fields, research protocols, storage/handling notes, and interaction guidance below are shown with their evidence labels, but calculator presets and exact dosing math remain hidden until the record is verified or reaches Community-Supported status.
Quick Facts
Reference Sizes
100 g, 250 g, 500 g, 1 kg, 240 capsules
Storage
Store tightly sealed at room temperature in a dry location
Solubility
Water-soluble crystalline amino acid
Best-Effort Research Profile
Beta-alanine is a nonessential amino acid and the rate-limiting substrate for muscle carnosine synthesis. Trials usually use divided daily loading for weeks rather than an acute pre-workout dose. Evidence is strongest for some high-intensity efforts lasting more than about one minute, but reviews and expert groups do not fully agree on the practical benefit.
Source review pending. This descriptive profile is shown from the available source material as a best-effort educational reference. It has not passed the full verification bar and is not a dosing instruction, medical claim, or treatment recommendation.
Research Profile
Half-Life
Plasma clearance is less relevant than cumulative muscle-carnosine loading; no dosing decision should be based on one simple half-life
Onset
Muscle-carnosine and performance effects are generally assessed after at least 2-4 weeks
Administration Routes (Research)
Oral
Reported Research Effects
Raises muscle carnosine over weeks
May improve selected high-intensity exercise outcomes
Not a universal endurance or strength enhancer
Reported Research Side Effects
Paresthesia at larger single doses
Pruritus reported
Long-term safety beyond about one year is not established
Data source: NIH dietary-supplement evidence review plus current retail and scientific catalogs
Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.
Route-Specific Research Protocols
Amounts and schedules are separated by administration route. Evidence badges distinguish labels, human studies, preclinical work, community reports, and evidence gaps.
Label / guidelineHuman studyCommunity onlyPreclinical onlyNot established
OralHuman study only
4-6 g/day in divided doses
Frequency / timing
Divided doses with meals
Duration / setting
At least 2-4 weeks
Technique
Oral
Evidence
Human study protocol
Context: NIH ODS summary of ISSN protocol and trial evidence
Formulation: Oral-mucosal formulations are not dose-equivalent to injectable or topical formulations.
Route safety: Research-study protocol only; it is not an approved or individualized instruction and should not be extrapolated to another route.
Do not convert an amount between routes. Bioavailability, formulation, sterility, monitoring, and clinical context differ by route. Research-use context only; independently verify every cited source.
Research Notes
Current retail and laboratory markets consistently list 100 g, 250 g, 500 g, and 1 kg powder, with 240-count capsules also common.
Supplementary research context only. Not medical advice or a treatment recommendation.
Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.
Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.